Skip to content
ProPublica Donate
ProPublica Donate
Health Care

Sloan Kettering’s Crisis

A Reckoning Over Industry Ties

Memorial Sloan Kettering Cancer Center in New York is re-examining conflicts of interest after articles by ProPublica and The New York Times highlighted the relationships between its staff and health care companies.

Impact of Our Reporting
Caret

Sloan Kettering’s Crisis

Top Official at Memorial Sloan Kettering Resigns After Failing to Disclose Industry Ties

Dr. José Baselga, the hospital’s chief medical officer, stepped down days after a report by ProPublica and the New York Times that he failed to disclose millions of dollars in payments from the health care and drug industry in research articles.

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

14 stories published since 2018

Memorial Sloan Kettering Gave Top Doctor $1.5 Million After He Was Forced to Resign Over Conflicts of Interest

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Memorial Sloan Kettering Leaders Violated Conflict-of-Interest Rules, Report Finds

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

Memorial Sloan Kettering Curbs Executives’ Ties to Industry After Conflict-of-Interest Scandals

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Top Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Memorial Sloan Kettering’s Season of Turmoil

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Top Cancer Doctor Resigns as Editor of Medical Journal

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Sloan Kettering Cancer Researchers Correct the Record by Revealing Company Ties

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

Memorial Sloan Kettering’s Chief Executive Resigns From Merck’s Board of Directors

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Cancer Center’s Board Chairman Faults Top Doctor, Saying He “Crossed Lines”

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

Facing Crisis, Sloan Kettering Tells Exec to Hand Over Profits From Biotech

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Cancer Center Switches Focus on Fundraising as Problems Mount

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

Sloan Kettering’s Cozy Deal With Start-Up Ignites a New Uproar

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

Sloan Kettering Cancer Center Orders Staff to “Do a Better Job” of Disclosing Industry Ties

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

What We’re Watching

During Donald Trump’s second presidency, ProPublica will focus on the areas most in need of scrutiny. Here are some of the issues our reporters will be watching — and how to get in touch with them securely.

Learn more about our reporting team. We will continue to share our areas of interest as the news develops.

Photo of Sharon Lerner
Sharon Lerner

I cover health and the environment and the agencies that govern them, including the Environmental Protection Agency.

Photo of Andy Kroll
Andy Kroll

I cover justice and the rule of law, including the Justice Department, U.S. attorneys and the courts.

Photo of Melissa Sanchez
Melissa Sanchez

I report on immigration and labor, and I am based in Chicago.

Photo of Jesse Coburn
Jesse Coburn

I cover housing and transportation, including the companies working in those fields and the regulators overseeing them.

If you don’t have a specific tip or story in mind, we could still use your help. Sign up to be a member of our federal worker source network to stay in touch.

We’re trying something new. Was it helpful?

Most Read
    The Ugly Truth

    “Incalculable” Damage: How a “We Buy Ugly Houses” Franchise Left a Trail of Financial Wreckage Across Texas

    Charles Carrier is accused of orchestrating a yearslong Ponzi scheme, bilking tens of millions of dollars from both wealthy investors and older people with modest incomes. Despite signs of trouble, HomeVestors didn’t intervene.

    by Anjeanette Damon and Mollie Simon,

    Trump Administration Moves to Block the U.S. Travel of Mexican Politicians Who It Says Are Linked to the Drug Trade

    The list of Mexicans who could be targeted for U.S. visa restrictions includes leaders of President Claudia Sheinbaum’s party, state governors and former Cabinet ministers.

    by Tim Golden,

    U.S. AG Pam Bondi Sold More than $1 Million in Trump Media Stock the Day Trump Announced Sweeping Tariffs

    Disclosure forms show that Bondi sold between $1 million and $5 million worth of shares on April 2. That day, after the market closed, Trump’s “Liberation Day” press conference sent the market tumbling.

    by Robert Faturechi and Brandon Roberts,

    The Trump Administration Leaned on African Countries. The Goal: Get Business for Elon Musk.

    The State Department has intervened on behalf of Musk’s satellite internet company in five developing nations. In Gambia, U.S. diplomats have lobbied and browbeat at least seven government ministers as part of a “maximum pressure” campaign.

    by Joshua Kaplan, Brett Murphy, Justin Elliott and Alex Mierjeski,

    On the Hook

    Connecticut Towing Companies Use Belongings Left in Cars as Leverage to Collect Fees, Drivers Say

    The Connecticut DMV allows owners to get back into towed cars to retrieve items that are essential to their health and welfare. But people have lost work equipment, car seats, important documents and priceless mementos.

    by Ginny Monk and Dave Altimari, The Connecticut Mirror,

    Local Reporting Network